Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Our Event History
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Upcoming Events
    • Past Events
      • World Stem Cell Summit
      • Regenerative Medicine and Stem Cell Action Awards
      • Regenerative Medicine Essentials
      • The “Art of Science” Inspires Students
      • Exploring Public Policy: Regenerative Medicine and Cell Therapies
      • Congressional Briefings
      • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
  • Donate
Select Page
Clinical Trial Results Buoy Hope for Spinal Cord Injury Patients

Clinical Trial Results Buoy Hope for Spinal Cord Injury Patients

by Bernard Siegel | Mar 16, 2017 | News & Opinions, Science

The Miami Project to Cure Paralysis, at the University of Miami Miller School of Medicine,has announced the publication of its first Food and Drug Administration (FDA) approved Phase I clinical trial involving Schwann cells used to repair the damaged spinal cord. The...

Recent Posts

  • UC Berkeley researchers discover ancestor of gene-editing tool CRISPR
  • Could Inhaled Cell Therapy Change the Course of COPD?
  • Healthspan Action Coalition and Leading Italian Organizations Announce Global Collaboration
  • Launching “Healthspan for All” at the Translational Longevity Summit
  • 3D-printed spheroids enable dual bone and vascular tissue development
Tweets about @WSCSummit